Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.

Ruff CT, Bonaca MP, Kosowsky JM, Conrad MJ, Murphy SA, Jarolim P, Donahoe SM, O'Donoghue ML, Morrow DA.

J Thromb Thrombolysis. 2013 Nov;36(4):361-7. doi: 10.1007/s11239-013-0870-7. Erratum in: J Thromb Thrombolysis. 2013 Nov;36(4):368.

PMID:
23328883
2.

Diabetes and mortality following acute coronary syndromes.

Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, Antman EM.

JAMA. 2007 Aug 15;298(7):765-75.

PMID:
17699010
3.

Adding clopidogrel to aspirin improves outcome in ST-elevation myocardial infarction patients receiving fibrinolytic therapy.

Donahoe SM, Sabatine MS.

Expert Rev Pharmacoecon Outcomes Res. 2005 Dec;5(6):751-61. doi: 10.1586/14737167.5.6.751.

PMID:
19807617
4.

Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.

Metzner KJ, Moretto WJ, Donahoe SM, Jin X, Gettie A, Montefiori DC, Marx PA, Binley JM, Nixon DF, Connor RI.

J Gen Virol. 2005 Dec;86(Pt 12):3375-84.

PMID:
16298985
5.

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.

Rose NF, Marx PA, Luckay A, Nixon DF, Moretto WJ, Donahoe SM, Montefiori D, Roberts A, Buonocore L, Rose JK.

Cell. 2001 Sep 7;106(5):539-49.

6.

Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.

Komanduri KV, Donahoe SM, Moretto WJ, Schmidt DK, Gillespie G, Ogg GS, Roederer M, Nixon DF, McCune JM.

Virology. 2001 Jan 20;279(2):459-70.

7.

Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.

Larsson M, Messmer D, Somersan S, Fonteneau JF, Donahoe SM, Lee M, Dunbar PR, Cerundolo V, Julkunen I, Nixon DF, Bhardwaj N.

J Immunol. 2000 Aug 1;165(3):1182-90.

8.

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.

Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL.

J Exp Med. 2000 Jul 3;192(1):63-75.

9.

Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.

Donahoe SM, Moretto WJ, Samuel RV, Metzner KJ, Marx PA, Hanke T, Connor RI, Nixon DF.

Virology. 2000 Jul 5;272(2):347-56.

10.

Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.

Haslett PA, Nixon DF, Shen Z, Larsson M, Cox WI, Manandhar R, Donahoe SM, Kaplan G.

J Infect Dis. 2000 Apr;181(4):1264-72. Epub 2000 Apr 5.

PMID:
10751137
11.

Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells.

Spiegel HM, Ogg GS, DeFalcon E, Sheehy ME, Monard S, Haslett PA, Gillespie G, Donahoe SM, Pollack H, Borkowsky W, McMichael AJ, Nixon DF.

J Virol. 2000 Jan;74(2):1018-22.

12.

Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.

Nixon DF, Donahoe SM, Kakimoto WM, Samuel RV, Metzner KJ, Gettie A, Hanke T, Marx PA, Connor RI.

Virology. 2000 Jan 5;266(1):203-10.

13.

High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections.

Jin X, Demoitie MA, Donahoe SM, Ogg GS, Bonhoeffer S, Kakimoto WM, Gillespie G, Moss PA, Dyer W, Kurilla MG, Riddell SR, Downie J, Sullivan JS, McMichael AJ, Workman C, Nixon DF.

J Infect Dis. 2000 Jan;181(1):165-75.

PMID:
10608763
14.

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.

Ortiz GM, Nixon DF, Trkola A, Binley J, Jin X, Bonhoeffer S, Kuebler PJ, Donahoe SM, Demoitie MA, Kakimoto WM, Ketas T, Clas B, Heymann JJ, Zhang L, Cao Y, Hurley A, Moore JP, Ho DD, Markowitz M.

J Clin Invest. 1999 Sep;104(6):R13-8.

15.

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

Dhodapkar MV, Steinman RM, Sapp M, Desai H, Fossella C, Krasovsky J, Donahoe SM, Dunbar PR, Cerundolo V, Nixon DF, Bhardwaj N.

J Clin Invest. 1999 Jul;104(2):173-80.

16.

Supplemental Content

Loading ...
Support Center